Insulet Corp (MEX:PODD)
MXN 4702.68 0 (0%) Market Cap: 372.46 Bil Enterprise Value: 382.28 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 87/100

Insulet Corp at UBS Global Healthcare Conference Transcript

May 20, 2019 / 06:00PM GMT
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Okay. Thanks, everybody, for joining us for the session. We have with us management from the Insulet Corporation, and I want to introduce Shacey Petrovic, who is the President and CEO of Insulet, and she served as CEO since January 1 and on the Board since September 18, having been the COO for the last number of years. So welcome, Shacey. And then Wayde McMillan, running out another new role, new member of the management team, has served as EVP and CFO since March of 2019. And prior to that, spent several years as Medtronics' CFO and VP of Finance in the MITG Group. All right. So with that brief intro, Shacey, I want to give you chance to make some opening comments, talk a little bit about for Insulet is in the life cycle and then go to the [hot] room and then we'll get into some fireside chat Q&A.

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Right. Yes, sounds good. So thanks for having us, Matt. we're thrilled

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot